1.
Rules of Engagement: Molecular Insights from Host-Virus Arms Races
by Daugherty, Matthew D
Annual review of genetics, 2012, Vol.46 (1), p.677-700
2.
Effects of retroviruses on host genome function
by Jern, Patric
Annual review of genetics, 2008, Vol.42 (1), p.709-732
3.
The adherence gap: a longitudinal examination of men's and women's antiretroviral therapy adherence in British Columbia, 20002014
by Puskas, Cathy M
AIDS (London), 2017, Vol.31 (6), p.827-833
4.
5.
Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4
by Nicolás, David
Expert review of anti-infective therapy, 2015, Vol.13 (8), p.947-963
6.
Trends and determinants of survival for over 200000 patients on antiretroviral treatment in the Botswana National Program: 2002-2013
by Farahani, Mansour
AIDS (London), 2016, Vol.30 (3), p.477-485
7.
The Role of Internalized Stigma in the Disclosure of Injecting Drug Use Among People Who Inject Drugs and Self-Report as HIV-Positive in Kohtla-Jaerve, Estonia
by Johannson, Annika
AIDS and behavior, 2017, Vol.21 (4), p.1034-1043
8.
Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8Tscm Cells in Children with HIV Receiving Raltegravir
by Tuluc, Florin
AIDS research and human retroviruses, 2017, Vol.33 (2), p.133-142
9.
Effect of CD4 super(+) cell count and viral suppression on risk of ischemic stroke in HIV infection
by Chow, Felicia C
AIDS (London), 2014, Vol.28 (17), p.2573-2577
10.
Is it safe to drop CD4 super(+) monitoring among virologically suppressed patients: a cohort evaluation from Khayelitsha, South Africa
by Ford, Nathan
AIDS (London), 2014, Vol.28 (14), p.2003-2005
11.
Polymorphism in interleukin-7 receptor alpha gene is associated with faster CD4 super(+) T-cell recovery after initiation of combination antiretroviral therapy
by Hartling, Hans J
AIDS (London), 2014, Vol.28 (12), p.1739-1748
12.
Protease inhibitor monotherapy is not associated with increased viral replication in lymph nodes
by Vinuesa, David
AIDS (London), 2014, Vol.28 (12), p.1835-1840
13.
CD8 super(+)/CD161 super(++) mucosal-associated invariant T-cell levels in the colon are restored on long-term antiretroviral therapy and correlate with CD8 super(+) T-cell immune...
by Greathead, Louise
AIDS (London), 2014, Vol.28 (11), p.1690-1692
14.
HIV DNA in CD14 super(+) reservoirs is associated with regional brain atrophy in patients naive to combination antiretroviral therapy
by Kallianpur, Kalpana J
AIDS (London), 2014, Vol.28 (11), p.1619-1624
15.
HIV viral load levels and CD4 super(+) cell counts of youth in 14 cities
by Ellen, Jonathan M
AIDS (London), 2014, Vol.28 (8), p.1213-1219
16.
CD4 super(+) cell count at antiretroviral therapy initiation and economic restoration in rural Uganda
by Venkataramani, Atheendar S
AIDS (London), 2014, Vol.28 (8), p.1221-1226
17.
18.
Specific loss of cellular L-selectin on CD4 super(+) T cells is associated with progressive multifocal leukoencephalopathy development during HIV infection
by Schneider-Hohendorf, Tilman
AIDS (London), 2014, Vol.28 (5), p.793-795
19.
The link between CD8 super(+) T-cell antigen-sensitivity and HIV-suppressive capacity depends on HLA restriction, target epitope and viral isolate
by Lissina, Anna
AIDS (London), 2014, Vol.28 (4), p.477-486
20.
Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4 super(+) cell counts: findings from a cluster-randomized trial
by Woodd, Susannah L
AIDS (London), 2014, Vol.28 (4), p.569-576
